The total worldwide market for therapeutic vaccines is expected to reach $137 million in 2010 and $425 million in 2011. With increased product introductions, this market is expected to reach nearly $3.1 billion in 2014 at a 5 year CAGR of 117%.
Use this report to:
- Receive analysis for each therapeutic vaccine on the market and almost all therapeutic vaccines in mid-to-late stages of development, we have examined where they stand in the drug development process, major challenges to their approval or market success, achievements and, where applicable, the projected market for each of these drugs through 2014.
- Determine the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015
- See technical descriptions and challenges , applications, major players, international aspects, and projected growth for some of these therapeutic vaccines through 2014
- Understand trends that are assessed based on projected sales of new products being introduced, competitive advantages of emerging technologies as well as other factors such as increases in the prevalence of certain diseases; with forecasts by product segment and indications from 2009 through 2014 including supporting analysis for projections.
Posts
No comments:
Post a Comment